GSK plc has reached a confidential settlement regarding Zantac (ranitidine) litigation with Martin Gross, filed in Illinois; the case will be dismissed without GSK admitting liability. Despite the settlement, GSK asserts there's no reliable evidence linking ranitidine to cancer and will continue to defend its position.